Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes
Get Live Data
0.20    0.015 (8.11%)
Bid:
0.19
Ask:
0.21
Spread: 0.02 (10.526%)
Market Cap: £5.22m
NFX Live PriceLast checked at - London Stock Exchange

Intraday Nuformix Share Chart

New Accounting Ref Date

21 Sep 2016 07:00

RNS Number : 3814K
Levrett PLC
21 September 2016
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE UNITED STATES OF AMERICA OR SOUTH AFRICA OR ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

 

Levrett Plc

("Levrett" or "the Company")

 

Change of accounting reference date

  

Levrett announces that the Board has approved a change in its accounting reference date from 31 December to 31 March, effective from 31 March 2016. 

 

 

Enquiries:

Levrett Plc

Pascal Hughes, CEO

 

+44 (0) 20 7183 4342

 

 

Whitman Howard Limited

Niall Baird / Nick Lovering

 

+44 (0) 20 7659 1234

Gable Communications Limited

John Bick

+44 (0) 20 7193 7463

+44 (0) 7872 061007

 

levrett@gablecommunications.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NARLLFVAAVIIFIR
Date   Source Headline
31st Jan 20187:00 amRNSNXP002 Pilot Study in Lung and Liver Fibrosis
15th Dec 20177:30 amRNSAgreement to License NXP001
14th Dec 20177:00 amRNSDr Andy Richards Chairs Advisory Panel - New Appts
12th Dec 20174:40 pmRNSSecond Price Monitoring Extn
12th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20177:00 amRNSGrant of Warrants
1st Dec 20177:30 amRNSAppointment of Broker
10th Nov 201710:19 amRNSHolding(s) in Company
1st Nov 201712:23 pmRNSHolding(s) in Company
23rd Oct 20177:30 amRNSHolding(s) in Company
19th Oct 20177:00 amRNSNXP001 agreement for pilot bioequivalence study
16th Oct 20177:00 amRNSAdmission and First Dealings
16th Oct 20177:00 amRNSCancellation Notice and Re-Admission
13th Oct 20173:44 pmRNSChange of Name
13th Oct 201712:35 pmRNSResult of Meeting and Completion of Acquisition
13th Oct 20177:00 amRNSHalf-year Report
22nd Sep 20177:00 amRNSFinal Results and Annual Report
15th Sep 20172:15 pmRNSProspectus re: Proposed Acquisition of Nuformix
20th Apr 20177:00 amRNSConvertible Loan Agreement
23rd Dec 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSAccounts for the period ended 31 March 2016
21st Sep 20167:00 amRNSNew Accounting Ref Date
16th Sep 20161:03 pmRNSPossible Acquisition and Suspension of Trading
29th Mar 20167:00 amRNSHalf Yearly Report
24th Feb 20167:00 amRNSBroker Appointment and Corporate Update
17th Dec 20157:00 amRNSPublication of Prospectus and First Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.